한방병원에 내원한 특발성 폐섬유화증 환자 82명에 대한 임상적 특징 분석; 후향적 차트 리뷰
Effects of Korean Medicine in Idiopathic Pulmonary Fibrosis Patients - A Retrospective Chart Review
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Objective: This study was designed to analyze the clinical features of idiopathic pulmonary fibrosis patients who attended a Korean medicine hospital and the treatment effects through retrospective chart reviews. Methods: The medical records of 82 outpatients who had been diagnosed with idiopathic pulmonary fibrosis and visited the Allergy, Immune, and Respiratory System Department of Kyung Hee Korean Medicine Hospital from 8 January 2015 to 8 January 2021 were retrospectively reviewed. To assess the treatment outcomes, we used the FVC (Forced Vital Capacity), DLCO (Diffusing capacity of the Lung for CO), 6-minute walk test, and HRCT (High Resolution Computed Tomography). Results: The study group consisted of 28 females and 54 males. The median age of the patients was 67.98±11.44 years. The chief complaints were cough (n=51) and dyspnea (n=49). Other frequent symptoms were general weakness (n=8), weight loss (n=4), and a fever (n=2). A total of 77 (93.90%) patients were prescribed Korean herbal medicine, and 52 (63.41%) patients were treated with acupuncture, moxibustion, cupping therapy, ICT, or pharmacopuncture. After treatments, FVC, DLCO, the 6-minute walk test, and HRCT were maintained or worsened slightly. Conclusions: This study presented the characteristics of idiopathic pulmonary fibrosis patients treated by Korean medical therapies, and further studies of Korean medical treatments for idiopathic pulmonary fibrosis patients would be valuable.
Abstract
Objective: This study was designed to analyze the clinical features of idiopathic pulmonary fibrosis patients who attended a Korean medicine hospital and the treatment effects through retrospective chart reviews. Methods: The medical records of 82 outpatients who had been diagnosed with idiopathic pulmonary fibrosis and visited the Allergy, Immune, and Respiratory System Department of Kyung Hee Korean Medicine Hospital from 8 January 2015 to 8 January 2021 were retrospectively reviewed. To assess the treatment outcomes, we used the FVC (Forced Vital Capacity), DLCO (Diffusing capacity of the Lung for CO), 6-minute walk test, and HRCT (High Resolution Computed Tomography). Results: The study group consisted of 28 females and 54 males. The median age of the patients was 67.98±11.44 years. The chief complaints were cough (n=51) and dyspnea (n=49). Other frequent symptoms were general weakness (n=8), weight loss (n=4), and a fever (n=2). A total of 77 (93.90%) patients were prescribed Korean herbal medicine, and 52 (63.41%) patients were treated with acupuncture, moxibustion, cupping therapy, ICT, or pharmacopuncture. After treatments, FVC, DLCO, the 6-minute walk test, and HRCT were maintained or worsened slightly. Conclusions: This study presented the characteristics of idiopathic pulmonary fibrosis patients treated by Korean medical therapies, and further studies of Korean medical treatments for idiopathic pulmonary fibrosis patients would be valuable.
참고문헌 (22)
- Rosas IO, "Interstitial lung disease:NHLBI workshop on the primary prevention of chronic lung diseases", Annals of the American Thoracic Society, 11(Supplement 3), pp.S169~S177 (2014)
- Cottin V, "Presentation, diagnosis and clinical course of the spectrum of progressive- fibrosing interstitial lung diseases", European Respiratory Review, 27(150), pp.180076~ (2018)
- Richeldi L, "Idiopathic pulmonary fibrosis", The Lancet, 389(10082), pp.1941~1952 (2017)
- Network IPFCR, "Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis", New England Journal of Medicine, 366(21), pp.1968~1977 (2012)
- Raghu G, "An official ATS", ERS, ALAT statement:idiopathic pulmonary fibrosis:evidence-based guidelines for diagnosis and management, pp.American journal of respiratory and critical care medicine, 2011[DOI]
- Saito S, "Pharmacotherapy and adjunctive treatment for idiopathic pulmonary fibrosis (IPF)", Journal of thoracic disease, 11(Suppl 14), pp.S1740~ (2019)
- Son JY, "A Clinical Case Report of Diffuse Interstitial Lung Disease", The Journal of Internal Korean Medicine, (fal), pp.111~116 (2008)
- Ahn JM, "The Effects of Lung-Moistening Herbal Medicines on Bleomycin-Induced Pulmonary Fibrosis Mouse Model", Processes, 8(1), pp.102~ (2020)
- 전국한의과대학 폐계내과학교실, "폐계내과학", pp.464~ (2019), 도서출판 나도
- Richeldi L, "Relative versus absolute change in forced vital capacity in idiopathic pulmonary fibrosis", Thorax, 67(5), pp.407~411 (2012)
- Zappala CJ, "Marginal decline in forced vital capacity is associated with a poor outcome in idiopathic pulmonary fibrosis", European Respiratory Journal, 35(4), pp.830~836 (2010)
- du Bois RM, "6-Minute walk distance is an independent predictor of mortality in patients with idiopathic pulmonary fibrosis", European Respiratory Journal, 43(5), pp.1421~1429 (2014)
- Ichikado K, "Acute interstitial pneumonia:comparison of high-resolution computed tomography findings between survivors and nonsurvivors", American journal of respiratory and critical care medicine, 165(11), pp.1551~1556 (2002)
- Oda K, "High-resolution CT scoring system-based grading scale predicts the clinical outcomes in patients with idiopathic pulmonary fibrosis", Respiratory research, 15(1), pp.1~9 (2014)
- 권병수, "2018년 개정 지침에 따른 특발성 폐섬유증의 진단", 대한내과학회지, 94(2), pp.173~181 (2019), 대한내과학회[DOI]
- 어수택, "특발성 폐 섬유화증: 병인 및 치료의 최신지견", 대한의사협회지, 52(1), pp.22~29 (2009), 대한의사협회
- Douglas WW, "Idiopathic pulmonary fibrosis:impact of oxygen and colchicine, prednisone, or no therapy on survival", American journal of respiratory and critical care medicine, 161(4), pp.1172~1178 (2000)
- Scott J, "What causes cryptogenic fibrosing alveolitis?A case-control study of environmental exposure to dust", British Medical Journal, 301(6759), pp.1015~1017 (1990)
- 백현정, "淸上補下湯을 복용한 천식, COPD 등 만성호흡기환자에 대한 후향적 연구 - IgE, Eosinophil, PFT를 중심으로 -", 대한한방내과학회지, 37(3), pp.484~494 (2016), 대한한방내과학회
- Jung HJ, "Liripois Tuber contributes to the chemotaxis of eosinophils and secretion of cytokines in A549 human epithelial cells", The Journal of Korean Oriental Chronic Disease, 10(1), pp.1~20 (2005)
- 張介賓, "景岳全書" (2006), 한미의학
- Collard HR, "Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis", American journal of respiratory and critical care medicine, 168(5), pp.538~542 (2003)
